Zhang JX - Search Results

1

Efficacy of third-line pemetrexed monotherapy versus pemetrexed combination with bevacizumab in patients with advanced EGFR mutation-positive lung adenocarcinoma.

Zhou CZ, Qin YY, Xie ZH, Zhang JX, Ou-Yang M, Li SY, Chen RC. Zhou CZ, et al. Among authors: zhang jx. Chin J Cancer Res. 2014 Dec;26(6):705-10. doi: 10.3978/j.issn.1000-9604.2014.12.19. Chin J Cancer Res. 2014. PMID: 25561769 Free PMC article.

2

Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer.

He C, Liu M, Zhou C, Zhang J, Ouyang M, Zhong N, Xu J. He C, et al. Int J Cancer. 2009 Nov 15;125(10):2393-9. doi: 10.1002/ijc.24653. Int J Cancer. 2009. PMID: 19530244

3

Fatal interstitial lung disease associated with icotinib.

Zhang J, Zhan Y, Ouyang M, Qin Y, Zhou C, Chen R. Zhang J, et al. J Thorac Dis. 2014 Dec;6(12):E267-71. doi: 10.3978/j.issn.2072-1439.2014.10.24. J Thorac Dis. 2014. PMID: 25590006 Free PMC article.

4

NPTX1 is a novel epigenetic regulation gene and associated with prognosis in lung cancer.

Zhou C, Qin Y, Xie Z, Zhang J, Yang M, Li S, Chen R. Zhou C, et al. Biochem Biophys Res Commun. 2015 Mar 6;458(2):381-6. doi: 10.1016/j.bbrc.2015.01.124. Epub 2015 Jan 31. Biochem Biophys Res Commun. 2015. PMID: 25646694

5

Efficacies and adverse reactions of modified vitamin supplement programs before pemetrexed chemotherapy as a second-line treatment against epidermal growth factor receptor (EGFR) mutant wild-type lung adenocarcinoma.

Zhou C, Qin Y, Ming O, Xie Z, Zhang J, Li S, Chen R, Zhong N. Zhou C, et al. Int J Clin Exp Med. 2015 Aug 15;8(8):13716-23. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26550317 Free PMC article.

6

131I-chTNT injection to relieve tracheal obstruction in advanced NSCLC patient.

He M, Li S, Chen Y, Ouyang M, Chen P, Zhang J. He M, et al. Technol Health Care. 2016 Apr 29;24 Suppl 2:S513-9. doi: 10.3233/THC-161176. Technol Health Care. 2016. PMID: 27163312

7

RACK1 forms a complex with FGFR1 and PKM2, and stimulates the growth and migration of squamous lung cancer cells.

Zhou C, Chen T, Xie Z, Qin Y, Ou Y, Zhang J, Li S, Chen R, Zhong N. Zhou C, et al. Mol Carcinog. 2017 Nov;56(11):2391-2399. doi: 10.1002/mc.22663. Epub 2017 Sep 15. Mol Carcinog. 2017. PMID: 28418088

8

Detection of Rare Mutations in EGFR-ARMS-PCR-Negative Lung Adenocarcinoma by Sanger Sequencing.

Liang C, Wu Z, Gan X, Liu Y, You Y, Liu C, Zhou C, Liang Y, Mo H, Chen AM, Zhang J. Liang C, et al. Yonsei Med J. 2018 Jan;59(1):13-19. doi: 10.3349/ymj.2018.59.1.13. Yonsei Med J. 2018. PMID: 29214771 Free PMC article.

9

miR‑802 inhibits the aggressive behaviors of non‑small cell lung cancer cells by directly targeting FGFR1.

Zhang J, Li J, Li S, Zhou C, Qin Y, Li X. Zhang J, et al. Int J Oncol. 2019 Jun;54(6):2211-2221. doi: 10.3892/ijo.2019.4765. Epub 2019 Mar 29. Int J Oncol. 2019. Retraction in: Int J Oncol. 2022 Sep;61(3):99. doi: 10.3892/ijo.2022.5389 PMID: 30942425 Retracted.

10

Unexpected favorable outcome to etoposide and cisplatin in a small cell lung cancer transformed patient: a case report.

Xie Z, Gu Y, Lin X, Ouyang M, Qin Y, Zhang J, Liu J, Mai S, Zhou C. Xie Z, et al. Cancer Biol Ther. 2019;20(9):1172-1175. doi: 10.1080/15384047.2019.1617561. Epub 2019 Jun 4. Cancer Biol Ther. 2019. PMID: 31161851 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,938 results

Search Page

Filters